This information was published on 2026-03-18T11:57:23 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2635973 |
| (220) |
16 Mar 2026
|
| (300) |
US, 30 Sep 2025, 99421485
|
| (511) (510) |
Class 42
Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy; Research in the field of gene editing technology; Providing a gene editing platform for others to conduct pharmaceutical research and development in the field of in vivo gene editing therapy |
| (540) | SYNTASE |
| (550) | Word |
| (730) |
CRISPR Therapeutics AG
|
| (750) |
Griffith Hack
|
Find out more about publications on the About page.